stockrowMaravai LifeSciences Holdings, Inc.
MRVI Healthcare Biotechnology
Maravai LifeSciences Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $185.7 million, down 28.3% from fiscal 2024.
- Revenue
- +10.1%
- EPS
- +50.0%
- Free cash flow
- +123.9%
- Total debt
- −45.4%
Quarter to September 2026, against a year earlier
Follow MRVI
Alert me
Maravai LifeSciences Holdings, Inc. (MRVI) Total debt
Maravai LifeSciences Holdings, Inc.'s total debt at the end of fiscal 2025 was $321.9M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $176.5M. Over the past ten years it has ranged from $321.9M (fiscal 2025) to $590.8M (fiscal 2020) — the current reading is the lowest in ten years. Maravai LifeSciences Holdings, Inc. ranks 63rd of 569 Biotechnology companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $321.9M | (1.57%) |
| FY2024 | $327.0M | (41.18%) |
| FY2023 | $556.0M | 5.42% |
| FY2022 | $527.4M | (0.59%) |
| FY2021 | $530.6M | (10.19%) |
| FY2020 | $590.8M | 51.40% |
| FY2019 | $390.2M | 14.80% |
| FY2018 | $339.9M | — |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $176.5M | (0.12%) |
| Jun 2026 | $176.7M | (34.77%) |
| Mar 2026 | $270.9M | (15.85%) |
| Dec 2025 | $321.9M | (0.41%) |
| 22 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| SRPT Sarepta Therapeutics, Inc. compare | $857.4M |
| MRVI Maravai LifeSciences Holdings, Inc. | $176.5M |
| HRMY Harmony Biosciences Holdings, Inc. compare | $149.1M |
| VIR Vir Biotechnology, Inc. compare | $128.0M |
| MESO Mesoblast Limited compare | $126.9M |
| REPL Replimune Group, Inc. compare | $121.2M |
| MAZE Maze Therapeutics, Inc. compare | $39.0M |
| TRVI Trevi Therapeutics, Inc. compare | $31.0K |
| TRAX First Tracks Biotherapeutics, Inc. compare | — |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt